Data isn’t just an asset—it’s a trust marker. In life sciences, our credibility hinges on who contributes data and whether…
President Trump said recently that the United States will announce a “major” tariff on pharmaceutical imports “very shortly.”
In 2023, Sheldon Ekirch was diagnosed with small fiber neuropathy, which makes her limbs and muscles feel as if they’re…
First Digital Health App United States Approval for Migraine Treatment with a Comprehensive Indication of Use
As a physician, I spend much of my day helping people navigate serious illnesses. But even outside of cancer, some…
When Medicine Transcends the Sterile Clinical Encounter
As the U.S. slashes foreign aid, Europe rewires its model — less charity, more strategic investment.
Medications subject to tariff could mean a return to readily available cultural, homeopathic medications.
Despite Record Funding, Clinical Validation Gap Threatens Long-Term Growth of Consumer HealthTech Market
It’s time to speak with a shared voice in defense of our health security
This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.
Read More